Please login to the form below

Not currently logged in
Email:
Password:

AZ files Crestor patent lawsuits in US

AstraZeneca files patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol-lowering blockbuster Crestor

UK-based pharmaceutical company, AstraZeneca (AZ), has filed patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol blockbuster Crestor (rosuvastatin).

The lawsuits were filed in US District Court against the US-based companies Cobalt, Aurobindo Pharma, Par Pharmaceutical, Mylan Pharmaceuticals and Sun Pharmaceutical. Canada's Apotex and Germany's Sandoz International are also involved.

Crestor is AZ's third-best-selling treatment, with FY06 sales of USD 2bn. Shares in the company dropped in value by 0.9 per cent to reach GBP 22.77 (USD 46.58) in midday trading on 12 December 2007 in London.

12th December 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...

Infographics